We examined the effect of antigen source on an enzyme-linked immunosorbent assay (ELISA) for autoantibodies against oxidized low-density lipoprotein (LDL). Serum samples from 20 subjects with systemic lupus erythematosus (SLE) and from 20 controls were assayed for immunoglobulin G (IgG) and immunoglobulin M (IgM) autoantibodies against oxidized LDL, using either a pooled or individual (n = 3) LDL preparation as antigen. For IgG autoantibodies against oxidized LDL there was a relationship (r~0'5, P<O·Ol) between data obtained using individual versus pooled antigen preparations. Bias plots demonstrated consistent inverse, concentration-dependent relationships (r~-0'6, P<O·OOI). The difference in IgG autoantibodies against oxidized LDL levels between SLE patients and controls was underestimated (39-58%) when assays used individual rather than pooled LDL antigen. For IgM autoantibodies against oxidized LDL the direct relationships were stronger (r~0·8, P<O·OOl) and the concentration-dependent relationships weaker (r~~0'3, significance variable) than for IgG autoantibodies against oxidized LDL. Variations between LDL preparations suggested that a pooled antigen would give a more stable assay. Thus, LDL antigen source is important in assays for both IgG and IgM autoantibodies against oxidized LDL.
INTRODUCTION
Oxidative processes are now believed to play an important role in the development of atherosclerosis.' Thus, evaluation of oxidation status may ultimately have clinical utility in the identification of those at risk for this disease. However, as oxidation is such a complex process it has proven difficult to establish which of the many potential oxidation-associated analytes would provide the most useful clinical information. 2.3 Furthermore, the direct assay of these analytes is fraught with many technical issues, not the least of which is the very practical concern of sample auto-oxidation. Autoantibodies against oxidized low-density lipoprotein (LDL) are found in the serum of most individuals," and it has been suggested' that their measurement might prove a useful indirect measure of serum oxidation status. Studies of their association with clinical conditions mostly support their relevance in this context, although several different approaches to synthesizing oxidized LDL antigen have been used, and much remains to be learned about which antigenautoantibody subsets are the most relevant clinically. Elevated levels of autoantibodies against oxidized LDL have been shown to be associated with atherosclerosis.r '! as well as with other conditions where inflammation (and hence the production of oxygen radicals) is evident, such as systemic lupus erythematosus (SLE),12,13 juvenile rheumatoid arthritis," and renal disease.'> At present, our ability to evaluate the clinical utility of measuring serum levels of autoantibodies against oxidized LDL is hampered by the lack of both a standard assay method and a common reference material. Assay techniques vary widely between laboratories.l? making the assimilation and interpretation of available clinical data difficult, and the definition of a normal reference range impossible. Before assay standardization can occur, however, it is important to learn more about how technical variations can impact assay results and the conclusions drawn from them. One area known to present problems is the batch-to-batch variation in LDL antigen.!" Furthermore, there are no published data available concerning the optimal source for LDL antigen. In this study, we have examined the effect of the LDL antigen format (single donor versus multiple donor pool) on the results of enzyme-linked immunosorbent assay (ELISA) assays for both immunoglobulin G (IgG) and immunoglobulin M (IgM) autoantibodies against oxidized LDL.
METHODS

Study samples
Experiments were performed using serum samples from 20 subjects with SLE, received in our laboratory for rheumatologic testing (2 men and 18 women, aged 26-76 years), and from 20 healthy volunteers (4 men and 16 women, aged 30-58 years). All samples were stored in aliquots at -70 DC for < 6 months prior to analysis and samples were identified by code alone to protect confidentiality. Sampling procedures were in accordance with the Helsinki Declaration of 1975, as revised in 1983, and with the ethical standards of the Foundation for Blood Research Institutional Review Board.
Low-density lipoprotein isolation and modification LDL was isolated from ethylenediarninetetraacetic acid (EDTA) plasma from three donors (A, Band C) by sequential ultracentrifugation. 17 The donors were three apparently healthy female volunteers aged 36-38 years with no family history of premature coronary artery disease and having LDL cholesterol levels within normal limits «3·37mmol/L). To prevent degradation due to bacterial growth, proteolysis or auto-oxidation LDL was prepared and stored at 4DC in the presence of 100 J.lg/mL gentamicin, 50 J.lg/mL chloramphenicol, I mrnol/L phenylmethylsulphonyl fluoride, 2'7mmol/L EDTA, 2mmol/L benzarnidine, 0·01 % aprotinin (Sigma Chemical Co., St. Louis, MO, USA) and 1 J.lM D-phenylalanyl-L-prolyl-L-arginine chloromethyl ketone (Chemica Alta, Edmonton, Canada). Aliquots were taken from each LDL preparation and combined to give an LDL pool (ABC). Half Ann cu« Biochem 1999: 36 of the material from each source (A, B, C and ABC) was used to prepare separate preparations of rnalondialdehyde-modificd LDL (MLDL) according to the method of Palinski et al. I K As described previously, 1] the extent of LDL oxidation was evaluated by assaying thiobarbituric reactive substances (TBARS). Modification was performed to give MLDL with TBARS of 9-12nmol/lOOJ.lg protein (native LDL had TBARS of <0·2nmol/100J.lg protein). In the assay of autoantibodies against oxidized LDL each MLDL preparation was paired with its respective native LDL (nLDL) preparation (e.g., LDL-A with MLDL-A or LDL-ABC with MLDL-ABC). Native and malondialdehydemodified LDL antigen preparations were stable for at least 8 weeks at 4"C; 1] the present studies were all performed within this time frame.
Assay of autoantibodies against oxidized LDL IgG and IgM autoantibodies against MLDL were assayed by ELISA as described previously, I] with the modification that sodium azide was omitted from the wash buffer. In both assays, the antigen (nLDL or MLDL) was coated at 25 J.lg/mL and the serum dilution was I:250. The dilutions of horseradish-peroxidaseconjugated rabbit anti-human IgG and horseradish-peroxidase-conjugated rabbit anti-human IgM (Jackson Immune Research, Westgrove, PA, USA) were 1:3000 and 1:2000 in the IgG and IgM assays respectively. To minimize between-run variability a serum pool (n = 3 serum samples) was assayed on each plate. Data were calculated both as the difference in antibody binding between nLDL and MLDL (MLDL-nLDL) and as the MLDL:nLDL binding ratio. For each method of calculation, data were expressed as a percentage of the value for the serum pool run on the same plate, as described previously. J] Serum samples were assayed in triplicate. To reduce precision-related bias, serum samples from controls and cases were alternated within each plate.
Statistical analyses
The relationships between data obtained using pooled versus individual LDL antigen sources were examined by paired t-tests and by linear regression. The concentration-dependent effects in these relationships were examined using linear regression of bias plots, where for each data point [(single antigen value -pooled antigen valuer/pooled antigen value] x 100 = J' and [pooled antigen value] = x. Differences in serum levels of autoantibodies against oxidized LDL between normal and SLE subjects were examined by Student's t-test. When necessary, data were transformed by taking the logarithm to give a Gaussian distribution, prior to statistical analysis.
RESULTS
Assay precision
Within-run and between-run coefficients of variation (CY) for the assay of IgG autoantibodies against oxidized LDL were 10·5 and 5·6%, respectively and for the assay of IgM autoantibodies against oxidized LDL were 5·2 and 10·0%, respectively (data calculated as MLDL-nLDL). For the individual LDL preparations (A, B and C), with autoantibodies against oxidized LDL calculated as MLDL-nLDL (n = 40), the between-batch CY was 18-2± 12·7% for the IgG assay and 8-5±4'6% for the IgM assay.
Relationships between IgG and IgM autoantibodies against oxidized LDL
The relationships between IgG and IgM autoantibodies against oxidized LDL data were inconsistent, and varied both with the batch of LDL antigen and with the method of calculating the data. When data were calculated as the MLDLnLDL ratio there were no significant associations between IgG and IgM autoantibodies against oxidized LDL (n = 40) (r = 0-183, 0,203,0,224 and 0·213 for assays using pooled LDL antigen, LDL antigen A, LDL antigen B and LDL antigen C. respectively). In contrast, when data were calculated as the MLDL-nLDL difference there was a significant relationship between IgG and IgM autoantibodies against oxidized LDL when pooled LDL antigen was used (r = O'348, P = 0'028). Associations between IgG and IgM autoantibodies against oxidized LDL were, however, inconsistent between individual LDL antigen batches [r = 0-130, 0·426 (P= 0-006) and 0·293 for LDL antigen batches A, Band C, respectively].
IgG and IgM autoantibodies against oxidized LDL: effects of antigen source The relationships between data obtained using either individual or pooled LDL antigen preparations were examined by linear regression analysis and are shown for assays of both IgG and IgM autoantibodies against oxidized LDL in Table I _ As similar results were found when control and SLE subjects were examined separately (not shown), data from the entire study group (n = 40) were combined in these analyses. There were statistically significant relationships between data obtained using pooled and individual antigen preparations. These relationships were consistent in extent for a given assay among the three individual antigen preparations and were similar between methods of calculating the data (MLDL-nLDL difference or MLDLnLDL ratio). The assays for IgG and IgM autoantibodies against oxidized LDL differed in the extent of the observed relationships, with the IgG assay demonstrating a weaker association (r~0-5) than the IgM assay (r~0'8) between results obtained using pooled and individual antigen preparations.
The above analyses do not address potential concentration-dependence effects in the relationship between assays performed using pooled or individual antigen preparations. We therefore TABU' I_ differences between controls and SLE subjects in these relationships (data not shown). There were strong inverse concentration-dependent relationships between pooled and individual antigen preparations, regardless of the method used for calculating data (sC'C' Table 2 ). Thus, for each of the three individual antigen preparations tested, low levels of autoantibodies against oxidized LDL were overestimated and high levels of autoantibodies against oxidized LDL were underestimated, compared with values obtained using a pooled antigen preparation. Next, we examined concentration-dependent relationships between pooled and individual antigen preparations in the assay for IgM autoantibodies against oxidized LDL. As illustrated in Fig. 2 , the data demonstrated inverse concentration-dependent relationships between single or pooled antigen sources. These relationships were weaker and also less consistent between LDL batches (sC'C' Table 3 ) than were those observed using the assay for IgG autoantibodies against oxidized LDL (sC'C' Table 2 ).
Autoantibodies against oxidized LDL: the relationship between data obtained using pooled versus individual antigen preparations
IgG autoantibodies against oxidized LDL: impact of concentration-dependent bias due to antigen source
The implication of the concentration-dependent bias related to antigen is that if levels of autoantibodies against oxidized LDL differ between two hypothetical groups of subjects, TABLE antigen formats in the assay of IgG autoantibodies against oxidized LDL. The expected differences between control and SLE subjects were seen regardless of whether the data were expressed as the difference between or the ratio of MLDL and nLDL binding (see Table 4 ). The extent of the difference between subgroups was, however, larger when pooled antigen was used, compared with the three individual LDL antigen preparations. The average difference between controls and SLE subjects obtained using the single LDL antigen preparations was 53% of the difference obtained using pooled antigen when data were calculated as MLDL-nLDL, and 39% of the difference obtained using pooled antigen when data were calculated as the MLDL:nLDL ratio. As well as measuring a potential risk factor or marker for atherosclerosis, the assay of autoantibodies against oxidized LDL shows promise as a tool that can be used to increase our understanding of the pathogenesis of atherosclerosis. The authors'<!? and others" have shown, however, that technical differences in the assay can have a significant effect on the results obtained and the inferences made in a given experimental situation. In the present experiments we have explored the effect on the assay of LDL antigen format, comparing individual LDL antigen preparations with pooled preparations derived from three serum this difference will be smaller when the antigen is derived from a single LDL preparation compared with a pooled LDL preparation. As it is well established that levels of IgG autoantibodies against oxidized LDL are higher in SLE than in non-SLE controls.P'!' we used this system as a model to explore the practical impact of concentration-dependent bias between samples. Further work is needed to optimize the antigen pool characteristics in terms of the number and clinical characteristics of the plasma samples included. Also, for the assay of IgG autoantibodies against oxidized LDL we have used the known difference between control and SLE subjects'<P as a model to determine whether the choice of pooled or individual LDL antigen source could alter the conclusions of between-subgroup comparisons. The largest discrepancies in data between pooled and single LDL antigen sources were seen in the assay for IgG autoantibodies against oxidized LDL. In this assay there was a relatively weak direct correlation between results obtained using the two antigen sources, most likely due to the presence of a strong, inverse, concentration-dependent relationship between assays using pooled versus individual LDL antigen sources. Consistent with this inverse relationship, the difference between control and SLE subgroups was less in the assay that used single LDL antigen, compared with the assay that used pooled LDL antigen. The data also confirm our previous finding!' that differences in serum levels of autoantibodies against oxidized LDL between study subgroups are greater when data are calculated as the difference in absorbance rather than as the MLDL:LDL ratio. This is likely to be due to the fact that the former calculation is less affected by the presence of non-specific binding." Thus, in the assay for IgG autoantibodies against oxidized LDL, pooled LDL is the preferred antigen when evaluating differences between two groups.
IgG autoantibodies against oxidized LDL: regression analysis of"bias plOTS
For IgM autoantibodies against oxidized LDL, the strong direct correlation between results obtained using pooled or individual Ann C/in Biochem 1999: 36 LDL antigen preparations, together with weaker and less consistent concentration-dependent relationships between the two assay formats, suggests that LDL antigen source is a less important factor than in the IgG assay. Nevertheless, as the data indicated marked variations in the behaviour of the assay between individual LDL antigen batches, the use of pooled LDL as antigen is likely to result in a more stable assay.
The cause of the observed inconsistencies in the concentration-dependent relationships between different individual LDL antigens and pooled LDL antigen in the assay for IgM (but not IgG) autoantibodies against oxidized LDL is not immediately apparent. One possible explanation may be related to the findings of Wu and Lcfvcrt.i" who reported that IgG autoantibodies against oxidized LDL were not only of higher affinity, but also more heterogeneous with regard to affinity, than were IgM autoantibodies against oxidized LDL. Thus, binding of the more heterogeneous IgG autoantibody population may be less affected than that of IgM autoantibodies by minor variations in epitope structure between antigen sources.
The clinical associations of IgM autoantibodies against oxidized LDL have been studied less frequently than have those of IgG autoantibodies against oxidized LDL. If consistent associations between IgM anti-oxidized LDL and atherosclerosis are seen this may indicate that the epitope structure of oxidized LDL is changing constantly, leading to chronic stimulation of the immune system by neoantigen. Salonen et al. l ll found that IgG (but not IgM) autoantibodies against oxidized LDL were associated with the progression of carotid atherosclerosis, while Maggi et at.' found that Effeci of antigen source on oxidized LDL autoantibody assay 339 both IgG and IgM autoantibodies against oxidized LDL were elevated in association with carotid atherosclerosis. Jansen et al. 2 1 found that levels of IgM autoantibodies against oxidized LDL were higher in subjects with small dense LDL, compared with those having more buoyant LDL. while levels of IgG autoantibodies against oxidized LDL did not differ between the two groups. The present data show inconsistent relationships between IgG and IgM autoantibodies against oxidized LDL due to variations in assay and calculation format. This indicates that assay characteristics may contribute to observations that IgM and IgG autoantibodies against oxidized LDL differ in their clinical associations.
In summary, the present data indicate that use of a pooled LDL antigen source is preferred over a single LDL antigen source for assays of both IgG and IgM autoantibodies against oxidized LDL. For the assay of IgG autoantibodies against oxidized LDL, this conclusion is based on strong, inverse, concentration-dependent relationships between data obtained using the two antigen sources; for the assay of IgM autoantibodies against oxidized LDL, pooled LDL antigen is preferred due to inconsistencies in data among individual LDL batches.
